Surgical resection and transplantation are the classic treatment methods for liver cancer. The Institute for Radiology at the Kantonsspital Baden (KSB) now also offers stereotactic tumour ablations to patients. The KSB uses state-of-the-art technology from CAScination.
In the current issue (02-2018) of the referrer magazine KSB-Update, KSB presents its new range of treatments. The decisive factor in KSB's decision to rely on CAScination's navigation technology for the treatment of tumour patients was not least the high level of safety and precision of the CAS-One IR interventional navigation system.
The treatments carried out under image guidance of a computer tomograph (CT) allow detailed planning of the intervention tailored to the patient. Thanks to stereotactic navigation, ablation needles can be placed in all regions of the liver with very high accuracy and their position can then be validated. This enables a complete ablation of the tumors including the corresponding safety distances.
With regular ablation treatments, KSB aims to make a significant contribution to improving the care situation for patients in its catchment area.
Read the full article in KSB-Update 02-2018
CAScination AG is an award-winning medical technology company dedicated to development, manufacturing and commercialization of innovations in computer-assisted and image-guided surgery. Our trailblazing navigation systems and surgical robots are designed to improve outcomes for patients undergoing surgical or interventional procedures and offer new perspectives to patients worldwide. Our CAS-One planning and navigation system is used to treat patients suffering from soft tissue cancer (e.g., liver cancer) by many hospitals across Europe, and we are developing further applications in a number of disease areas.
Fon + 41 (0) 31 552 0440